Zahra Shafaghat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zahra Shafaghat has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Fatemeh Faraji
Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran
2 shared publications - Mona Roozbehani
Vaccine Research Center, Iran University of Medical Sciences, Tehran, Iran
2 shared publications Ali Hussein Mer
Department of Nursing, Mergasour Technical Institute, Erbil Polytechnic University, Erbil, Iraq
1 shared publication- Ali Moazzeni
Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Iranian Blood Transfusion Organization (IBTO), Tehran, Iran
1 shared publication - Amir Hossein Mansourabadi
Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Arezoo Rajabian
Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication
Latest Publications
- 3 September 2025
- Published by Springer Nature in Journal of Nanoparticle Research
- Vol. 27 (9) , 1-13
Novel insights into possible ZnO nanoparticle-induced changes in key metabolic enzymes in HeLa cervical cancer cell line
- 3 September 2025
- Published by Springer Nature in Journal of Nanoparticle Research
- Vol. 27 (9) , 1-13
Novel insights into possible ZnO nanoparticle-induced changes in key metabolic enzymes in HeLa cervical cancer cell line
- 20 February 2024
- Published by Knowledge E DMCC in Iranian Journal of Allergy, Asthma and Immunology
- Vol. 23 (1) , 1-28
The Role of Innate and Adaptive Immune System in the Pathogenesis of Schizophrenia
Chizophrenia is one of the most severely debilitating mental disorders that affects 1.1% of the world's population. The exact cause of the disease is not known, but genetics, environmental factors (such as infectious agents, season and region of birth, exposure to viruses, low birth weight, advanced paternal age, and tobacco), and immune system dysfunction can all contribute to the development of schizophrenia. Recently, the role of the immune system in schizophrenia has received much attention. Both acquired and innate immune systems are involved in the pathogenesis of schizophrenia and facilitate the disease's progression. Almost all cells of the immune system including microglia, B cells, and T cells play an important role in the blood-brain barrier damage, inflammation, and in the progression of this disease. In schizophrenia, the integrity of the blood-brain barrier is reduced and then the immune cells are recruited into the endothelium following an increase in the expression of cell adhesion molecules. The entry of immune cells and cytokines leads to inflammation and antibody production in the brain. Accordingly, the results of this study strengthen the hypothesis that the innate and acquired immune systems are involved in the pathogenesis of schizophrenia.
- 20 February 2024
- Published by Knowledge E DMCC in Iranian Journal of Allergy, Asthma and Immunology
- Vol. 23 (1) , 1-28
The Role of Innate and Adaptive Immune System in the Pathogenesis of Schizophrenia
Chizophrenia is one of the most severely debilitating mental disorders that affects 1.1% of the world's population. The exact cause of the disease is not known, but genetics, environmental factors (such as infectious agents, season and region of birth, exposure to viruses, low birth weight, advanced paternal age, and tobacco), and immune system dysfunction can all contribute to the development of schizophrenia. Recently, the role of the immune system in schizophrenia has received much attention. Both acquired and innate immune systems are involved in the pathogenesis of schizophrenia and facilitate the disease's progression. Almost all cells of the immune system including microglia, B cells, and T cells play an important role in the blood-brain barrier damage, inflammation, and in the progression of this disease. In schizophrenia, the integrity of the blood-brain barrier is reduced and then the immune cells are recruited into the endothelium following an increase in the expression of cell adhesion molecules. The entry of immune cells and cytokines leads to inflammation and antibody production in the brain. Accordingly, the results of this study strengthen the hypothesis that the innate and acquired immune systems are involved in the pathogenesis of schizophrenia.
- Open Access
- 29 April 2023
- Published by Springer Nature in Archives of Virology
- Vol. 168 (5) , 1-13
B lymphocytes in COVID-19: a tale of harmony and discordance
B lymphocytes play a vital role in the human defense against viral infections by producing specific antibodies. They are also critical for the prevention of infectious diseases by vaccination, and their activation influences the efficacy of the vaccination. Since the beginning of coronavirus disease 2019 (COVID-19), which became the main concern of the world health system, many efforts have been made to treat and prevent the disease. However, for the development of successful therapeutics and vaccines, it is necessary to understand the interplay between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, and the immune system. The innate immune system provides primary and nonspecific defense against the virus, but within several days after infection, a virus-specific immune response is provided first by antibody-producing B cells, which are converted after the resolution of disease to memory B cells, which provide long-term immunity. Although a failure in B cell activation or B cell dysfunction can cause a severe form of the disease and also lead to vaccination inefficiency, some individuals with B cell immunodeficiency have shown less production of the cytokine IL-6, resulting in a better disease outcome. In this review, we present the latest findings on the interaction between SARS-CoV-2 and B lymphocytes during COVID-19 infection.
- 29 April 2023
- Published by Springer Nature in Archives of Virology
- Vol. 168 (5) , 1-13
Open AccessB lymphocytes in COVID-19: a tale of harmony and discordance
B lymphocytes play a vital role in the human defense against viral infections by producing specific antibodies. They are also critical for the prevention of infectious diseases by vaccination, and their activation influences the efficacy of the vaccination. Since the beginning of coronavirus disease 2019 (COVID-19), which became the main concern of the world health system, many efforts have been made to treat and prevent the disease. However, for the development of successful therapeutics and vaccines, it is necessary to understand the interplay between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, and the immune system. The innate immune system provides primary and nonspecific defense against the virus, but within several days after infection, a virus-specific immune response is provided first by antibody-producing B cells, which are converted after the resolution of disease to memory B cells, which provide long-term immunity. Although a failure in B cell activation or B cell dysfunction can cause a severe form of the disease and also lead to vaccination inefficiency, some individuals with B cell immunodeficiency have shown less production of the cytokine IL-6, resulting in a better disease outcome. In this review, we present the latest findings on the interaction between SARS-CoV-2 and B lymphocytes during COVID-19 infection.